Home/Filings/4/0001437749-25-019624
4//SEC Filing

DODD DAVID A 4

Accession 0001437749-25-019624

CIK 0000832489other

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 9:35 AM ET

Size

5.8 KB

Accession

0001437749-25-019624

Insider Transaction Report

Form 4
Period: 2025-06-05
DODD DAVID A
Director
Transactions
  • Award

    Stock Option

    2025-06-05+185,500185,500 total
    Exercise: $2.48Exp: 2035-01-02Common Stock (185,500 underlying)
Footnotes (2)
  • [F1]Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.
  • [F2]This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan. Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance.

Issuer

GeoVax Labs, Inc.

CIK 0000832489

Entity typeother

Related Parties

1
  • filerCIK 0001193607

Filing Metadata

Form type
4
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 9:35 AM ET
Size
5.8 KB